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Abstract 
The anodic behaviour of carbamazepine (CBZ), an anticonvulsant drug, has been studied
on gold electrode in 0.1 mol dm
–3 phosphate buffer of pH 7.0 by using cyclic voltammetry.
It has been found that the value of the oxidative current of pure CBZ at 0.90 V vs. SCE is a 
linear function of the concentration in a range from 1.0×10
–7 to 1.0×10
−4 mol dm
−3. The 
detection of CBZ in the concentration of 1.0×10
–8 mol dm
–3 is among the lowest that have 
been reported for this drug using voltammetric techniques. CBZ as a content of tablet Gal-
epsine® has been quantitatively determined. It has also been demonstrated that the modi-
fication of gold electrode with bovine serum albumin (BSA) results in a decrease of the
oxidative peak current due to the binding of the drug to BSA. 
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Carbamazepine (CBZ) is one of the safest and the 
most effective anticonvulsant drugs, which is used in 
the management of tonic-clonic, complex partial and 
mixed-type seizures for a long time [1,2] (Fig. 1). Cur-
rently, various mechanisms of its action are proposed. 
The anticonvulsant activity of CBZ principally involves 
limitation of seizure propagation by reduction of post-
tetanic potentiation of synaptic transmission [3]. The 
drug has also demonstrated sedative, anticholinergic, 
antidepressant, muscle relaxant, antiarrhythmic, antidi-
uretic and neuromuscular transmission inhibitory actions 
[4]. 
 
Figure 1. Chemical structure of carbamazepine (5H-dibenzo-
[b,f]azepine-5-carboxamide). 
Several analytical methods have been presented in 
the literature for the determination of CBZ and its 
impurities in the bulk drug and biological fluids. Fluor-
escence polarization immunoassay [5] and HPLC [6–8] 
are usually used for the routine determination of this 
and other anticonvulsant drugs. Conventional chroma-
tographic techniques, such as gas chromatography 
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[9,10], gas chromatography combined with mass spec-
trometry [11] and micellar electrokinetic capillary chro-
matography [12] have also been employed. Few recent 
studies have investigated the applicability of electro-
chemical methods for the characterization of CBZ. Its 
electrochemical oxidation at glassy carbon electrode 
(GCE) in phosphate buffer solution (pH 7.4) has been 
studied by Kalanur and Seetharamappa [13]. Two oxi-
dation peaks have been observed, whereby no peak 
has been observed in the reverse scan suggesting that 
the oxidation process is an irreversible one. The prob-
able reaction mechanism of oxidation of CBZ has been 
proposed based on the reported mechanism of oxi-
dation of imipramine (3-(10,11-dihydro-5H-dibenzo-
[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine), which 
has an almost similar structure and belongs to same 
class of tricyclic compounds. Taking into account that 
the voltammogram of imipramine closely resembled 
that of CBZ, the authors have proposed that the reac-
tion mechanism includes the oxidation of CBZ to a radi-
cal, which dimerizes rapidly and subsequently under-
goes oxidation to form a dimmer radical. Veiga et al. 
have applied a multiwalled carbon nanotubes film- 
-coated GCE for the voltammetric determination of CBZ 
in phosphate buffer solution (pH 6.89) [14]. The elec-
trochemical reduction of CBZ in acetonitrile and dime-
thylformamide using GCE and microelectrode has also 
been studied [15]. The reduction process is suggested 
to follow electrochemical–chemical mechanism involv-
ing a two electron transfer accompanied by a first order 
reaction. Pruneanu et al. have employed graphene– 
–gold nanoparticle composite deposited on gold elec-
trode to detect CBZ [16]. A two-wave oxidation peak 
has been observed accompanied by a small reduction N.P. TRIŠOVIĆ et al.: DETERMINATION OF CARBAMAZEPINE  Hem. ind. 68 (2) 207–212 (2014) 
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peak, which have suggested an oxidation pathway with 
formation of dimmers similar to the one proposed in 
[13]. Lin et al. have used differential pulse voltametry 
to determine the serum level of CBZ in rabbits and 
reported a detection limit of 59.2×10
–8 mol dm
–3 [17]. 
Excellent enhancement effects on electrochemical res-
ponse of CBZ have been achieved through the use of 
fullerene–C60 modified GCE [18]. Cyclic voltammogram 
has shown two oxidation and reduction peaks at ful-
lerene–C60 modified GCE in phosphate buffer solution 
(pH 7.2). In this case, a detection limit of 16.2×10
–9 mol 
dm
–3 has been reported. 
Different electrode materials have offered possib-
ilities for improving the electrochemical behavior of 
CBZ, as well as for reaching lower limits of its detection. 
The aim of this paper is at first the investigation of the 
electrochemical behaviour of CBZ (pharmaceutical 
standard) on gold electrode and gold electrode modi-
fied with BSA using cyclic voltammetry. The electroche-
mical identification of its tablet content is presented in 
this regard. The proposed method is observed to be 
very sensitive and allows determination of CBZ in a 
wide concentration range in solid dosage forms. 
EXPERIMENTAL 
Materials 
The CBZ standard (Sigma Aldrich) was used as a 
pure substance without further purification, dissolved 
(1 vol.% of methanol and 99 vol.% of phosphate buffer) 
and added into the electrolyte (0.1 mol dm
–3 phosphate 
buffer, pH 7.0), so that the final range of the drug con-
centrations was 1.0×10
–8–1.0×10
–4 mol dm
–3.  
The commercial CBZ, as a content of Galepsin® tab-
lets (Galenika a.d., Serbia), was dissolved in methanol 
and added into the electrolyte (0.1 mol dm
-3 phosphate 
buffer, pH 7.0); the final range of concentrations was 
1.0×10
–6–1.0×10
–4 mol dm
–3. BSA (Sigma Aldrich) was 
used as a pure substance without further purification 
and modification. Phosphate buffer solution was pre-
pared by standard procedure and pH has been mea-
sured by Mettler Toledo (FiveGo) pH Meter. Monobasic 
sodium phosphate and dibasic sodium phosphate were 
p.a. purity. Water was purified by Milli-Q system. 
Apparatus and preparation of electrode surfaces 
Standard equipment was used for the cyclic voltam-
metry measurements and the three electrode electro-
chemical cell was described in detail previously [19– 
–21]. Polycrystalline gold (bare gold) served as the 
working electrode; a gold wire was used as the counter 
electrode and a saturated calomel electrode as the 
reference electrode. All the potentials are given vs. SCE. 
Prior to the addition of CBZ, the electrolyte was deoxy-
genated by purging with nitrogen. All the experiments 
were performed at room temperature. 
BSA modified gold electrode was prepared by trans-
ferring a droplet of 2×10
–6 cm
3 of BSA solution onto the 
surface of gold electrode and by air-drying overnight. 
The electrode was then soaked in sterile water for at 
least 4 h before being rinsed with water to remove any 
unadsorbed BSA [22]. 
Polycrystalline gold (surface area 0.500 cm
2), which 
served as the working electrode, was polished with 
diamond paste, cleaned with a mixture of 18 MΩ cm 
deionised water and sulfuric acid and further cleaned 
with 18 MΩ cm deionised water in an ultrasonic bath. 
RESULTS AND DISCUSSION 
Due to its low water solubility (∼72×10
–5 mol dm
–3 
at 25 °C), the electrochemical characterization of CBZ 
has been mostly performed with addition of organic 
solvents such as acetonitrile and dimethylformamide 
[14–17]. However, these solvents interact with the 
surface of gold electrode and easily adsorb on it [23], 
which makes them inconvenient for the purposes of 
the present research. In the initial experiment, we have 
employed bicarbonate solution as electrolyte, but the 
obtained cyclic voltammogram of CBZ has shown its 
low electrooxidation activity when compared with the 
ones obtained in phosphate buffer solution. Because of 
this, phosphate buffer has been further used for the 
electrochemical determination of CBZ. To overcome 
the problem of the low solubility of CBZ and excipients 
used in tablet (Galepsin®), methanol has been added to 
the electrolyte (0.1 and 1 vol.% for the determination 
of CBZ as pharmaceutical standard and tablet content, 
respectively). It has already been shown that methanol 
is not electroactive on gold electrode at the value of 
the applied sweep rate (50 mV s
–1) [24]. 
In the presence of the CBZ standard (at the concen-
tration of 1.0×10
–8 mol dm
–3), the reaction of the oxi-
dation occurs in the area of the oxide formation with 
the apparent anodic activity from 0.90 to 1.10 V, as it is 
presented in Fig. 2. The small lowering of the first gold 
oxide peak at 0.75 V is also apparent only for the con-
centration of 1.0×10
–8 mol dm
–3. In the reverse sweep, 
the reaction of the oxide reduction has been decreased 
in the presence of CBZ at 0.44 V, which may be attri-
buted to the reduction of products formed in the des-
cribed anodic reactions, as it is the case with macrolide 
antibiotics [19–21]. Furthermore, for the all of the 
investigated concentrations of CBZ from 1.0×10
–7 to 
1.0×10
–4 mol dm
−3, in anodic direction,
 cyclic voltam-
mograms exhibited the changed shape compared to 
the cyclic voltammograms in the presence of 1.0×10
–8 
mol dm
–3 of
  CBZ, as well as in its absence. The 
increasing anodic current values from 0.30 to 1.10 V 
due to the increased CBZ concentrations lead to the N.P. TRIŠOVIĆ et al.: DETERMINATION OF CARBAMAZEPINE  Hem. ind. 68 (2) 207–212 (2014) 
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formation of the current shoulder with the maximum 
value at 0.95 V. The first gold oxide peak at 0.75 V 
completely diminished as shown in Fig. 2. Because it 
has tendency to undergo poisoning after the first 
sweep, gold electrode has been polished between suc-
cessive additions of suitable aliquots of the working 
solution of CBZ in phosphate buffer solution to obtain 
good reproducible results, improved sensitivity and 
resolution of voltammetric peaks. Comparing to GCE, 
gold electrode does not require anodic pretreatment 
for its activation and its polishing and cleaning between 
the consecutive concentrations of analyte is quite 
simple and cheap procedure [13]. Both electrodes exhi-
bit abilities for efficient, fast simple and cheap voltam-
metric determination of CBZ. The value of the oxidative 
currents of pure CBZ at 0.90 V in 0.1 dm
−3 phosphate 
buffer at the scan rate of 50 mV s
−1 is a linear function 
of the concentration in a range of 1×10
–7–1×10
–4 mol 
dm
−3. This linearity is presented by Eq. (1) and given in 
the left corner of Fig. 2: 
j (mA cm
–2) = 0.0588 + 83.3c (mol dm
–3), R = 0.998  (1) 
Thus, the proposed method, using cyclic voltam-
metry on gold electrode, enabled the detection of CBZ, 
even at the concentration of 1.0×10
–8 mol dm
–3, which 
is among the lowest that have been reported for this 
drug using voltammetric techniques so far [1, 18]. 
The voltammetric characterization of CBZ, as a con-
tent of tablets (Galepsin®) in the concentration range 
from 1.0×10
–6 to 1.0×10
–4 mol dm
−3, is presented in Fig. 
3. The cyclic voltammograms of Galepsin® tablets 
shows the same shape and the current maximum at 
1.10 V, as it is observed for the standard. The negligible 
smaller anodic activity from 0.80 to 1.00 V may be 
attributed only to the presence of the excipients. The 
present excipients obviously do not affect the electro-
oxidation of CBZ and enable its quantitative determi-
nation as content of tablets (Galepsin®). 
The value of the oxidative currents of CBZ (in 
Galepsin®) at 0.90 V vs. SCE in 0.1 mol dm
−3 phosphate 
buffer solution at the scan rate of 50 mV s
−1 is a linear 
function of the concentration in the range of 1.0×10
–6– 
–1.0×10
–4 mol dm
−3. This linearity is presented by Eq. 
(2) and given in the left corner of Fig. 3: 
j (mA cm
–2) = 0.0506 + 118c (mol dm
–3), R = 0.995  (2) 
Serum albumin is the most abundant protein in 
blood plasma and is responsible for the binding and 
transportation of various drugs. BSA is an ideal model 
protein for serum albumin due to its availability, stab-
 
Figure 2. The cyclic voltammograms of bare gold electrode (black line) and in the presence of the carbamazepine (CBZ) standard in 
the concentration from 1.0×10
–8 to 1.0×10
–4 mol dm
–3 (1.0×10
–8 mol dm
–3 pink line, 1.0×10
–7 mol dm
–3 blue line, 1.0×10
–6 mol dm
–3 
green line, 1.0×10
–5 mol dm
–3 orange line, 1.0×10
–4 mol dm
–3 red line) in 0.1 mol dm
–3 phosphate buffer (pH 7.0), sweep rate 50 mV 
s
–1 (only the first sweep is recorded). Inset: The dependency of the value of the oxidative currents of CBZ at 0.90 V on the 
concentration in the range 1.0×10
–7–1.0×10
–4 mol dm
−3. N.P. TRIŠOVIĆ et al.: DETERMINATION OF CARBAMAZEPINE  Hem. ind. 68 (2) 207–212 (2014) 
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ility and incomparable binding property [25]. The elec-
trochemical behaviour of various proteins at gold elec-
trode surfaces has been widely investigated in recent 
years (e.g., a gold electrode modified by gelatin [26], 
nafion-riboflavin [27], BSA [28]). To study the binding of 
CBZ to plasma proteins, its electrochemical behaviour 
on gold electrode modified with BSA, has been inves-
tigated, whereby a decrease of the oxidative peak cur-
rents as a result of the drug adsorption on the surface 
of the modified electrode has been expected. Figure 4 
represents the cyclic voltammogram of gold electrode 
modified with BSA, as well as in the presence of the 
CBZ standard at the concentration of 1.0×10
–4 mol dm
–3 
in 0.1 mol dm
–3 phosphate buffer solution. This concen-
tration of the drug has been chosen, because its blood 
plasma levels may range from 2.1×10
–6 to 1.1×10
–4 mol 
dm
–3 [29]. 
Gold modified by BSA exhibited almost two times 
lower currents in the whole region of the applied 
potential, which results from the strong adsorption of 
BSA on gold. It can be seen that the oxidative peak 
current has been decreased after adding the CBZ stan-
dard at the concentration of 1.0×10
–4 mol dm
–3 due to 
the binding of the drug to BSA. An ultraviolet and fluo-
rescence spectroscopic study has indicated that the 
interaction between CBZ and BSA in Tris-HCl buffer 
solution (pH 7.4) is mainly driven by the hydrophobic 
force; the apparent binding constant and the binding 
site values at 27 °C are 1.8×10
4 and 0.97, respectively [30]. 
 
Figure 4. The cyclic voltammograms of bare gold electrode 
(black line), modified with bovine serum albumine (red line) 
and in the presence of the carbamazepine standard (blue line) 
at the concentration of 1.0×10
–4 mol dm
–3 in 0.1 mol dm
–3 
phosphate buffer (pH 7.0), sweep rate 50 mV s
–1 (only the first 
sweep is recorded). 
 
Figure 3. The cyclic voltammograms of carbamazepine (CBZ) as a content of tablets (Galepsin®) in the concentration from 1.0×10
–6 
to 1.0×10
–4 mol dm
–3 (1.0×10
–6 mol dm
–3 blue line, 1.0×10
–5 mol dm
–3 green line, 1.0×10
–4 mol dm
–3 red line) in 0.1 mol dm
–3 
phosphate buffer (pH 7.0), sweep rate 50 mV s
–1 (only the first sweep is recorded). Inset: The dependency of the value of the 
oxidative currents of CBZ at 0.90 V on the concentration in the range 1.0×10
–6–1.0×10
–4 mol dm
−3. N.P. TRIŠOVIĆ et al.: DETERMINATION OF CARBAMAZEPINE  Hem. ind. 68 (2) 207–212 (2014) 
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CONCLUSION 
The proposed procedure enabled the detection of 
CBZ even at the concentration of 1.0×10
–8 mol dm
–3, 
which is among the lowest that have been reported for 
this drug using voltammetric techniques. Thus,  the 
anodic behaviour of CBZ on gold electrode in 0.1 mol 
dm
–3 phosphate buffer of pH 7.0 has shown that the 
value of the oxidative currents at 0.90 V vs. SCE is a 
linear function of the concentration in a range from 
1.0×10
–7 to 1.0×10
–4 mol dm
−3. The CBZ, as a content of 
tablet Galepsine®, has also been quantitatively deter-
mined in a range from 1.0×10
–6 to 1.0×10
–4 mol dm
−3.  
The electrooxidative behaviour of CBZ on gold elec-
trode modified with BSA indicates a strong interaction 
between the drug and BSA, which is mainly driven by 
the hydrofobic force.  
The simple, fast and cheap voltammetric procedure 
using gold electrode for the CBZ determination can be 
further developed as an additional method offering 
useful combinations with HPLC and with already inves-
tigated electrodes, such as glassy carbon electrode. 
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IZVOD 
ELEKTROHEMIJSKO KARAKTERISANJE I ODREĐIVANJE KARBAMAZEPINA KAO FARMACEUTSKOG STANDARDA I 
SADRŽAJA TABLETE NA ELEKTRODI OD ZLATA 
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(Naučni rad) 
Anodno ponašanje jednog od najsigurnijih i najefikasnijih  antikonvulzivnih 
lekova karbamazepina (CBZ) proučavano je po prvi put na elektrodi od zlata u 0.1
mol dm
–3 fosfatnom puferu pH 7.0 pomoću ciklične voltametrije. Karbamazepin
kao standard i kao sastojak komercijalnog oblika ( tablete) Galepsin® podleže 
anodnoj oksidaciji. Utvrđeno je da je vrednost struja oksidacije čistog CBZ-a na 
0.90 V linearna funkcija koncentracija u opsegu od 1.0×10
–7 do 1.0×10
−4 mol dm
−3. 
CBZ je detektovan i u koncentaraciji od 1.0×10
–8 mol dm
–3 koja je među najnižim 
koje su objavljene do sada za ovaj lek korišćenjem voltametrijskih tehnika. CBZ
kao sadržaj tablete Galepsin® je kvantitativno određen, pri čemu je na 0.90 V 
takođe dobivena linearna zavisnost vrednosti struja oksidacije od ispitivanih kon-
centracija leka (1.0×10
–6–1.0×10
–4 mol dm
−3). Pokazano je da prisutni ekscipijenti
u tableti ne utiču na proces elektrooksidacije CBZ u fosfatnom puferu. Takođe je
pokazano da modifikovanje elektrode od zlata albuminom goveđeg seruma (BSA)
ima za posledicu smanjenje struja oksidativnog pika CBZ-a usled vezivanja leka za 
BSA. Kvantitativno određivanje CBZ i kao sadrzaja tablete Galepsin® na elektrodi 
od zlata cikličnom voltametrijom u fosfatnom puferu pH 7.0 je brza, jednostavna i
efikasna metoda koja je korisna dopuna standardnoj metodi, tečnoj hromato-
grafiji visokih performansi (HPLC).
  Ključne reči: Karbamazepin • Voltamet-
rijsko određivanje • Elektroda od zlata 
 